http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7569344-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57f3e2af72b2933c004ed61dfccaaee1 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
filingDate | 2003-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e951280e9e81459774b2d529737fa518 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fa504ea723804b9689a7336c48fad3a |
publicationDate | 2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-7569344-B2 |
titleOfInvention | Detection of human papilloma virus in papanicolaou (Pap) smears |
abstract | Methods and reagents for detecting high-risk human papilloma virus (HPV) DNA types in cells on a Pap smear that indicates the patient is at higher risk for cancer are described. The method uses full-length DNA probes to HPV types 16, 18, 31, 33, 35, and 51 in a particular proportion to hybridize to and detect the viral DNA in situ. The method differentiates high-risk from low-risk HPV DNA in cells that indicates the patient's risk for cancer. The in situ hybridization is detected by brightfield microscopy. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9376727-B2 |
priorityDate | 1998-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.